Skip to main content

NEA Approved Features

There is growing evidence to support a hypothesis for the role pain may play in the disease process of atopic dermatitis. Test your knowledge of eczema-related pain with this short quiz!
Dawn M.R. Davis, MD
The following has been adapted from transcripts of Expert Insights in Atopic Dermatitis: Confronting Issues and Challenges Beneath the Surface, a multimedia content series examining atopic dermatitis at levels deeper than the skin’s surface. This series is developed in partnership with the National Eczema Association and is made possible through funding from AbbVie.
Vivian Shi, MD
The following has been adapted from transcripts of Expert Insights in Atopic Dermatitis: Confronting Issues and Challenges Beneath the Surface, a multimedia content series examining atopic dermatitis at levels deeper than the skin’s surface. This series is developed in partnership with the National Eczema Association and is made possible through funding from AbbVie.
Lauren Mateja, Managing Editor
Atopic dermatitis is a chronic disease requiring long-term monitoring of symptoms and triggers. Patients can proactively monitor their eczema with a new, easy-to-use mobile app.
Andrew Alexis, MD
Dr Alexis shares how he creates care plans for his patients with atopic dermatitis and shares insights on the current and future therapies.
Lauren Mateja, Managing Editor
As research continues to better differentiate between eczema and other diagnoses, the National Eczema Association continues to push awareness among patients and physicians with Eczema Awareness Month.
Peter Sonnenreich, Contributing Writer
New biologic therapy tralokinumab, a human monoclonal antibody targeting IL-13, is under FDA review for the treatment of atopic dermatitis.
Jonmichael W. Samsel, BS, Courtney E. Heron, BS, Steven R. Feldman, MD, PhD, Sarah L. Taylor, MD, MPH
Patients often describe seeking alternatives and adjuncts to care for the treatment of their atopic dermatitis. The literature has explored some of the potential in these options.
While much of research is to test the clinical efficacy and safety of drugs, these posters from the American Academy of Dermatology Virtual Meeting Experience 2020 focused on physician decision-making and evaluation, patient characteristics, and disease severity of eczema.
Jessica E. Payne, BS, Rima I. Ghamrawi, BS, Lindsay C. Strowd, MD
Atopic dermatitis can have a significant effect on the quality of life of all patients, especially for the children and adolescents who are primarily affected by the disease.
Back to Top